Home > Name List By other > [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid Canada

CAS No 114084-78-5 , [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid Search by region : Canada

  • Name: [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid
  • Synonyms: Ibandronate; 114084-78-5; Bondronat; Boniva; Bonviva; Bondronat (TN); Bisphosphonate 2; Acid ibandronico;[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid;
  • CAS Registry Number:
  • Transport: HAZARD
  • Melting Point: 113-115ºC
  • Flash Point: 309.3 ºC
  • Boiling Point: 587.8ºC at 760 mm
  • Density: 1.449 g/cm3
  • Refractive index: 1.537
  • Water Solubility: Soluble (insoluble in alcohols, organic solvents)
  • Hazard Symbols: UN NO.
  • Flash Point: 309.3 ºC
  • Molecular Weight: 319.228944
  • InchiKey: MPBVHIBUJCELCL-UHFFFAOYSA-N
  • InChI: InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,
    16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17)
  • Molecular Formula: C9H23NO7P2
  • Molecular Structure:CAS No:114084-78-5 [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid

Related products

Select to

114084-78-5 IBANDRONIC ACID

  • Canada TLC PharmaChem., Inc. [Manufacturer]
  • Tel: 905-760-1098
  • Fax: 905-760-2098
  • Address: TLC PharmaChem., Inc.
    5-150 Connie Crescent
    Concord, Ontario
    L4K 1L9, Canada null,nullCanada
Contact Supplier

114084-78-5 IBANDRONATE-D3 SODIUM

  • Canada Synth?se AptoChem Inc. [Manufacturer]
  • Tel: 514-496-4252
  • Fax: 514-496-4253
  • Address: Synth?se AptoChem Inc.
    6100 Royalmount Ave
    Montreal, QC
    Canada
    H4P 2R2 null,nullCanada
Contact Supplier

Select to

1/1
References of [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid
Title: Ibandronic Acid
CAS Registry Number: 114084-78-5
CAS Name: [1-Hydroxy-3-(methylpentylamino)propylidene]bisphosphonic acid
Molecular Formula: C9H23NO7P2
Molecular Weight: 319.23
Percent Composition: C 33.86%, H 7.26%, N 4.39%, O 35.08%, P 19.41%
Literature References: Bisphosphonate antiresorptive agent. Prepn: R. Gall, E. Bosies, DE 3623397; eidem, US 4927814 (1988, 1990 both to Boehringer Mann.). Inhibition of bone resorption: R. C. Mühlbauer et al., J. Bone Miner. Res. 6, 1003 (1991). Mechanism of action study: C. Vitté et al., Endocrinology 137, 2324 (1996). Clinical trial in cancer-associated hypercalcemia: M. Pecherstorfer et al., J. Clin. Oncol. 14, 268 (1996); in osteoporosis: P. Ravn et al., Bone 19, 527 (1996). Review of pharmacology and clinical efficacy: M. Dooley, J. A. Balfour, Drugs 57, 101-108 (1999); of clinical experience in osteoporosis: R. D. Chapurlat, P. D. Delmas, Expert Opin. Pharmacother. 4, 391-396 (2003); of development and therapeutic potential: L. Gennari, IDrugs 8, 155-169 (2005).
Properties: Dec 84°.
 
Derivative Type: Sodium salt
CAS Registry Number: 138926-19-9 (monohydrate); 138844-81-2 (anhydrous)
Synonyms: Ibandronate sodium
Manufacturers' Codes: BM-21.0955
Trademarks: Bondronat (Roche); Boniva (Roche); Bonviva (Roche)
Molecular Formula: C9H22NNaO7P2
Molecular Weight: 341.21
Percent Composition: C 31.68%, H 6.50%, N 4.11%, Na 6.74%, O 32.82%, P 18.16%
Properties: Occurs as the monohydrate.
 
Therap-Cat: Bone resorption inhibitor.
Keywords: Antiosteoporotic; Bone Resorption Inhibitor.